Pentamidine (inhalation)
Generic name
Pentamidine (inhalation)
Brand name
ATC Code
P01CX01
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Prophylaxis for pneumonia caused by Pneumocystis jirovecii (PCP) |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
In pneumonia due to Pneumocystis carinii, if co-trimoxazole has insufficient effect or is contraindicated.
Uncommon: acute hypotension, preferably to be administered on IC. Check the blood counts, blood pressure, serum creatinine and blood glucose.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Other agents against leishmaniasis and trypanosomiasis | ||
|---|---|---|
| P01CX01 | ||
Reference
- Hartwig NC, et al, Vademecum pediatrische antimicrobiele therapie, 2005
Changes
Therapeutic Drug Monitoring
Overdose
